As bone pain is a common symptom in cancer patients (31) and occurs in leukemia patients when the bone marrow expands due to the accumulation of abnormal white blood cells (32), it will be interesting to explore whether NK-1R antagonists can simultaneously abrogate this clinical symptom of leukemia patients. Here, TACR1 is linked to cancer.